Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 7, 2015, Pages 981-988

  Malentacchi, Francesca ^a   Mancini, Irene ^a   Brandslund, Ivan ^b   Vermeersch, Pieter ^a   Schwab, Matthias ^a   Marc, Janja ^a   Van Schaik, Ron H N ^a   Siest, Gerard ^a   Theodorsson, Elvar ^b   Pazzagli, Mario ^b   Di Resta, Chiara ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

" omics" technologies; Laboratory medicine; personalized medicine

Indexed keywords

ADMINISTRATIVE PERSONNEL; EUROPE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; LABORATORY; LABORATORY MEDICINE; MEDICAL EDUCATION; MEDICINE; PERSONALIZED MEDICINE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; HOSPITAL; LABORATORY TEST; MEDICAL SCHOOL; MEDICAL SOCIETY; ORGANIZATION AND MANAGEMENT;

CLINICAL LABORATORY TECHNIQUES; EDUCATION, MEDICAL; EUROPE; HOSPITALS; HUMANS; LABORATORIES; PRECISION MEDICINE; SCHOOLS, MEDICAL; SOCIETIES, MEDICAL; SURVEYS AND QUESTIONNAIRES;

EID: 84930801010     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2015-0171     Document Type: Review

References (30)

1. Siest G, Henny J, Grasbeck R, Wilding P, Petitclerc C, Queralto JM, et al. The theory of reference values: an unfinished symphony. Clin Chem Lab Med 2013;51:47-64.
2. Grbeck R, Saris NE. Establishment and use of normal values. Scand J Clin Lab Invest 1969;Suppl 110:62-3.
3. Berrahmoune H, Lamont J, Fitzgerald P, Visvikis-Siest S. Interindividual variation of inflammatory markers of cardiovascular risks and diseases. Clin Chem Lab Med 2005;43:671-84.
4. Vincent-Viry M, Schiele F, Gueguen R, Bohnet K, Visvikis S, Siest G. Biological variation and genetic reference values for apolipoprotein E serum concentrations: results from the STANISLAS cohort study. Clin Chem 1998;44:957-65.
5. Shahabi P, Siest G, Herbeth B, Ndiaye NC, Visvikis-Siest S. Clinical necessity of partitioning of human plasma haptoglobin reference intervals by recently-discovered rs2000999. Clin Chim Acta 2012;413:1618-24.
6. Goretti E, Wagner DR, Devaux Y. miRNAs as biomarkers of myocardial infarction: a step forward towards personalized medicine Trends Mol Med 2014;20:716-25.
7. Meade C, Bonhomme NF. Newborn screening: adapting to advancements in whole-genome sequencing. Genet Test Mol Biomarkers 2014;18:597-8.
8. Lin SY, Hsu WH, Lin CC, Chen CJ. Mass spectrometry-based proteomics in chest medicine, gerontology, and nephrology: subgroups omics for personalized medicine. BioMedicine 2014;4:25.
9. Ahmed MU, Saaem I, Wu PC, Brown AS. Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine. Crit Rev Biotechnol 2014;34:180-96.
10. Plebani M, Lippi G. Personalized (laboratory) medicine: a bridge to the future. Clin Chem Lab Med 2013:51;703-6.
11. Meyer UA, Zanger UM, Schwab M. Omics and drug response. Annu Rev Pharmacol Toxicol 2013;53:475-502.
12. European Commission Staff Working Document. Use of '-omics' technologies in the development of personalised medicine. Brussels, 25.10.2013 SWD 436 final, 2013.
13. Nofziger C, Papaluca M, Terzic A, Waldman S, Paulmichl M. Policies to aid the adoption of personalized medicine. Nat Rev Drug Discov 2014;13:159-60.
14. Pinho JR, Sitnik R, Mangueira CL. Personalized medicine and the clinical laboratory. Einstein 2014;12:366-73.
15. Ciardiello F, Arnold D, Casali PG, Cervantes A, Douillard JY, Eggermont A, et al. Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO). Ann Oncol 2014;25:1673-8.
16. Golubnitschaja O, Kinkorova J, Costigliola V. Predictive, preventive and personalised medicine as the hardcore of 'Horizon 2020': EPMA position paper. EPMA J 2014;5:6.
17. Melichar B. The highs and lows of tumor biomarkers: lost illusions. Clin Chem Lab Med 2015;53:343-7.
18. Lemke H, Golubnitschaja O. Towards personal health care with model-guided medicine: long-term PPPM-related strategies and realisation opportunities within 'Horizon 2020'. EPMA J 2014;5:8.
19. Cutica I, Mc Vie G, Pravettoni G. Personalised medicine: the cognitive side of patients. Eur J Int Med 2014;25:685-8.
20. Obara T, Abe S, Satoh M, Ubeda Gutierrez SR, Yoshimachi S, Goto T. Awareness regarding clinical application of pharmacogenetics among Japanese pharmacists. Pharmacogenomics Pers Med 2015;8:35-41.
21. Kricka LJ, Polsky TG, Park JY, Fortina P. The future of laboratory medicine-a 2014 perspective. Clin Chim Acta 2014;438C:284-303.
22. Arya SC, Hernandez JS, Dale JC, Bennet KE, Varkey P. Challenges and opportunities for medical directors in pathology and laboratory medicine: standardization, integration, and innovation. Am J Clin Pathol 2010;133:819-20.
23. Bossuyt X, Verweire K, Blanckaert N. Laboratory medicine: challenges and opportunities. Clin Chem 2007;53:1730-3.
24. Chrystoja CC, Diamandis EP. Whole genome sequencing as a diagnostic test: challenges and opportunities. Clin Chem 2014;60:724-33.
25. Macleod MR, Michie S, Roberts I, Dirnagl U, Chalmers I, Ioannidis JP, et al. Biomedical research: increasing value, reducing waste. Lancet 2014;383:101-4.
26. Hernandez JS, Dale JC, Bennet KE, Varkey P. Challenges and opportunities for medical directors in pathology and laboratory medicine: standardization, integration, and innovation. Am J Clin Pathol 2010;133:8-13.
27. Abul-Husn NS, Owusu Obeng A, Sanderson SC, Gottesman O, Scott SA. Implementation and utilization of genetic testing in personalized medicine. Pharmacogenomics Pers Med 2014;7:227-40.
28. Horgan D, Jansen M, Leyens L, Lal JA, Sudbrak R, Hackenitz E, et al. An index of barriers for the implementation of personalised medicine and pharmacogenomics in Europe. Public Health Genomics 2014;17:287-98.
29. Leyens L, Horgan D, Lal JA, Steinhausen K, Satyamoorthy K, Brand A. Working towards personalization in medicine: main obstacles to reaching this vision from today's perspective. Pers Med 2014;11:641-9.
30. Williams RJ. Biochemical Individuality: The Basis for the Genetotrophic Concept. John Wiley & Sons, 1956; University of Texas Press, 1969 to 1979; Keats Publishing, 1998.